FDA Inspection
Octapharma Plasma, Inc. PortsmouthOctapharma Plasma, Inc. Portsmouth – FDA Inspection, Sep 26, 2018
Record Details
This FDA Inspection record concerns Octapharma Plasma, Inc. Portsmouth, with an inspection on September 26, 2018, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 1706f69c-2306-4cb3-a0dc-55f575d46a92
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1066750
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 606.170(a)Adverse Reaction- Reports of Investigations
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Octapharma Plasma, Inc. Portsmouth
4| Date | Classification | Office | Project area |
|---|---|---|---|
| March 30, 2021 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 28, 2016 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 20, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 28, 2011 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Octapharma Plasma, Inc. Portsmouth
- FDA Inspection 1137609 - 2021-03-30
- FDA Inspection 992370 - 2016-10-28
- FDA Inspection 838033 - 2013-06-20
- FDA Inspection 733852 - 2011-06-28
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.